This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Abbvie Inc.. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2018
Title: Deanna L Haasch: Innovator in Cancer Treatment
Introduction
Deanna L Haasch is a prominent inventor based in Grayslake, IL (US). She has made significant contributions to the field of cancer treatment through her innovative work. With a total of three patents to her name, her research focuses on advanced therapeutic approaches.
Latest Patents
One of her latest patents is the Anti-DLL4/VEGF dual variable domain immunoglobulin and its uses. This patent discloses multivalent and multispecific binding proteins, along with methods for creating these proteins. The applications of these binding proteins are crucial for the diagnosis, monitoring, inhibition, prevention, and treatment of cancers, tumors, and other diseases that depend on angiogenesis, particularly those characterized by abnormal DLL4 and/or VEGF expression or activity.
Career Highlights
Deanna is currently associated with AbbVie Inc., where she continues to advance her research in the field of immunology and cancer therapies. Her work has been instrumental in developing new strategies for combating cancer.
Collaborations
Throughout her career, Deanna has collaborated with notable colleagues, including Jijie Gu and Dominic J Ambrosi. These partnerships have enhanced her research and contributed to the success of her innovative projects.
Conclusion
Deanna L Haasch is a trailblazer in the field of cancer treatment, with her patents paving the way for new therapeutic options. Her dedication to research and collaboration exemplifies the spirit of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile